Publications by authors named "Carsten Vock"

Claim this Profile
E
Erratum: Die bedeutende nicht-proteinogene Aminosäure Norleucin und ihre komplizierte Namensfindung.
Carsten A Vock

Chimia (Aarau)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Die bedeutende nicht-proteinogene Aminosäure Norleucin und ihre komplizierte Namensfindung.
Carsten A Vock

Chimia (Aarau)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L--Leucin als Konstitutionsisomer der proteino-genen Aminosäuren L-Leucin und L-Isoleucin: Herstellung sowie Vorkommen in Naturstoffen und als Baustein in Pharmaka.
Carsten A Vock

Chimia (Aarau)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites.
Fabienne Barna, Karim Debache, Carsten A Vock, Tatiana Küster, Andrew Hemphill

Antimicrob Agents Chemother· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis.
Tatiana Küster, Nadine Lense, Fabienne Barna, Andrew Hemphill, Markus K Kindermann, Carsten A Vock

J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2).
Christina Zimmer, Marieke Hafner, Michael Zender, Dominic Ammann, Rolf W Hartmann, Carsten A Vock

Bioorg Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases.
Ulrike E Hille, Christina Zimmer, Carsten A Vock, Rolf W Hartmann

ACS Med Chem Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls.
Ulrike E Hille, Qingzhong Hu, Carsten Vock, Matthias Negri, Marc Bartels

Eur J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed evolution of estrogen receptor proteins with altered ligand-binding specificities.
Kazi Mohammed Didarul Islam, Meik Dilcher, Corinna Thurow, Carsten Vock, Ilga Kristine Krimmelbein

Protein Eng Des Sel· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of novel structurally simplified estrogen analogues.
Lutz F Tietze, Carsten A Vock, Ilga K Krimmelbein, J Matthias Wiegand, Linda Nacke

Chemistry· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Carsten A Vock, Wee Han Ang, Claudine Scolaro, Andrew D Phillips, Lucienne Lagopoulos

J Med Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Carsten A Vock, Claudine Scolaro, Andrew D Phillips, Rosario Scopelliti, Gianni Sava

J Med Chem· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis